Cilcare strengthens its therapeutic pipeline with two new exclusive licensing agreements with Sanofi
CIL005 and CIL006 extend Cilcare’s pipeline to new mechanisms of hearing loss and new patient populationsMontpellier, France, November 16, 2026 – Cilcare, a biotechnology company pioneering auditory science, today announced…